Overview of receptor interactions of agonists and antagonists

Current Protocols in Pharmacology
Terry Kenakin

Abstract

Historically, the earliest methods used to quantitatively measure the fundamental properties of drugs (namely affinity and efficacy) employed isolated tissues, and it is in this realm that the null methods used to define "receptor pharmacology" were described. This unit describes these methods and their use to specifically classify agonists (through potency ratios and determination of relative affinities and efficacies) and antagonists (through analysis of surmountable and insurmountable antagonism) to yield estimates of potency. Different drugs can yield different behaviors in various tissues, so this unit is centered on a flow diagram to indicate the type of analysis appropriate for the behavior observed. For example, some agonists may be full agonists in some tissues and partial agonists in others, while some antagonists may demonstrate surmountable simple competitive antagonism in some tissues and insurmountable non-competitive antagonism in others. Methods exist for determination of affinity and efficacy for all of these behaviors, and these are delineated in this unit.

References

Jan 1, 1985·Journal of Cardiovascular Pharmacology·Terry Kenakin
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Mar 1, 1982·Canadian Journal of Physiology and Pharmacology·Terry Kenakin
May 31, 2002·Pharmacological Reviews·A Christopoulos, Terry Kenakin
Dec 1, 1956·British Journal of Pharmacology and Chemotherapy·R P STEPHENSON
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Aug 24, 1965·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·W D PATON, H P RANG
Jan 1, 1955·Quarterly Journal of Experimental Physiology and Cognate Medical Sciences·J H GADDUMF F STEPHENS
Jan 1, 1950·Biochimica Et Biophysica Acta·H A KREBS
Jul 22, 2006·The Journal of Pharmacology and Experimental Therapeutics·Terry KenakinChristian Watson
Sep 1, 1949·British Journal of Pharmacology and Chemotherapy·H O SCHILD

Citations

Mar 21, 2017·European Journal of Pharmacology·Martin HennenbergChristian Gratzke
Mar 27, 2018·British Journal of Pharmacology·Qingfeng YuMartin Hennenberg
Sep 1, 2017·American Journal of Physiology. Renal Physiology·Annika HerlemannMartin Hennenberg
Jan 6, 2011·Microbiology and Immunology·Aya Fukui-MiyazakiYasuhiko Horiguchi
Nov 5, 2010·Current Protocols in Toxicology·Cristina Pozzoli, Enzo Poli

Related Concepts

Dose-Response Relationship, Drug
Drug Antagonism
Receptors, Drug
Tissue Culture Techniques
Drug Agonism
Pharmacology
Antagonists
Agonists
Receptor
Analysis

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Laryngeal Neoplasms

Laryngeal Neoplasms occur in the Larynx and are typically associated with smoking and alcohol consumption. Discover the latest research on Laryngeal Neoplasms here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.